Shiqi Lin

机构：Capital Medical University, Nanjing University of Information Science and Technology, Peking University, University of Macau, China International Science and Technology Cooperation, Peking University Cancer Hospital, First Affiliated Hospital of Guangzhou Medical University, Beijing Shijitan Hospital, Guangzhou Medical University · ORCID：0000-0001-7388-8651

发表论文 132 篇 · 总被引 3035 次 · h-index 27

代表论文

• Sarcopenic Obesity and Outcomes for Patients With Cancer (2024 · JAMA Network Open · 被引 37)
• Obesity-associated metabolic inflammation promotes triple-negative breast cancer progression through the interleukin-6/STAT3/pentraxin 3/matrix metalloproteinase 7 axis (2024 · International Immunopharmacology · 被引 22)
• Reexamining in vivo fate of paclitaxel-loaded polymeric micelles (2024 · Nano Today · 被引 22)
• AWGC2023 cachexia consensus as a valuable tool for predicting prognosis and burden in Chinese patients with cancer (2024 · Journal of Cachexia Sarcopenia and Muscle · 被引 18)
• Reciprocal Interaction with Neutrophils Facilitates Cutaneous Accumulation of Liposomes (2024 · ACS Nano · 被引 18)
• Performance of anthropometry-based and bio-electrical impedance-based muscle-mass indicators in the Global Leadership Initiative on Malnutrition criteria for predicting prognosis in patients with cancer (2024 · Clinical Nutrition · 被引 16)